Efficacy and Safety of Rituximab in Chinese Children With Refractory Anti-NMDAR Encephalitis

Purpose: To assess the efficacy and safety of rituximab treatment as second-line immunotherapy in pediatric cases of anti-NMDA receptor (NMDAR) encephalitis. Methods: We retrospectively recruited 8 patients with anti-NMDAR encephalitis who were treated with rituximab as second-line immunotherapy. We...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Front Neurol
Egile Nagusiak: Dou, Xiangjun, Li, Dongjing, Wu, Yan, Wang, Zhijing, Yang, Le, Ma, Nan, Wang, Dong, Li, Xia
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Frontiers Media S.A. 2020
Gaiak:
Neurology
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7767921/
https://ncbi.nlm.nih.gov/pubmed/33381080
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fneur.2020.606923
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak